Daxor (DXR) Competitors $10.00 +0.03 (+0.30%) As of 08/6/2025 03:47 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DXR vs. SGHT, INGN, PDEX, TLSI, PROF, ELMD, KRMD, LNSR, RCEL, and LAKEShould you be buying Daxor stock or one of its competitors? The main competitors of Daxor include Sight Sciences (SGHT), Inogen (INGN), Pro-Dex (PDEX), TriSalus Life Sciences (TLSI), Profound Medical (PROF), Electromed (ELMD), KORU Medical Systems (KRMD), LENSAR (LNSR), Avita Medical (RCEL), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry. Daxor vs. Its Competitors Sight Sciences Inogen Pro-Dex TriSalus Life Sciences Profound Medical Electromed KORU Medical Systems LENSAR Avita Medical Lakeland Industries Sight Sciences (NASDAQ:SGHT) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, analyst recommendations and dividends. Does the media refer more to SGHT or DXR? In the previous week, Sight Sciences' average media sentiment score of 0.24 beat Daxor's score of 0.00 indicating that Sight Sciences is being referred to more favorably in the media. Company Overall Sentiment Sight Sciences Neutral Daxor Neutral Do institutionals and insiders have more ownership in SGHT or DXR? 55.5% of Sight Sciences shares are held by institutional investors. Comparatively, 1.3% of Daxor shares are held by institutional investors. 30.9% of Sight Sciences shares are held by company insiders. Comparatively, 59.5% of Daxor shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate SGHT or DXR? Sight Sciences presently has a consensus target price of $3.93, suggesting a potential upside of 6.88%. Daxor has a consensus target price of $25.00, suggesting a potential upside of 150.00%. Given Daxor's stronger consensus rating and higher possible upside, analysts clearly believe Daxor is more favorable than Sight Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29Daxor 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation and earnings, SGHT or DXR? Daxor has lower revenue, but higher earnings than Sight Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSight Sciences$79.87M2.38-$51.51M-$0.98-3.76DaxorN/AN/AN/AN/AN/A Which has more risk and volatility, SGHT or DXR? Sight Sciences has a beta of 2.44, suggesting that its stock price is 144% more volatile than the S&P 500. Comparatively, Daxor has a beta of -0.13, suggesting that its stock price is 113% less volatile than the S&P 500. Is SGHT or DXR more profitable? Daxor has a net margin of 0.00% compared to Sight Sciences' net margin of -63.24%. Daxor's return on equity of 0.00% beat Sight Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Sight Sciences-63.24% -54.62% -34.92% Daxor N/A N/A N/A SummaryDaxor beats Sight Sciences on 6 of the 11 factors compared between the two stocks. Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DXR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXR vs. The Competition Export to ExcelMetricDaxorMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$48.22M$3.76B$5.56B$9.47BDividend YieldN/A1.37%4.31%4.17%P/E RatioN/A32.1829.3723.99Price / SalesN/A151.75444.7496.71Price / CashN/A21.2735.8458.51Price / BookN/A4.108.085.58Net IncomeN/A$189.47M$3.26B$265.35M7 Day Performance0.81%1.58%0.44%-0.07%1 Month Performance1.42%-2.49%4.82%1.76%1 Year Performance17.79%3.98%30.27%25.39% Daxor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXRDaxorN/A$10.00+0.3%$25.00+150.0%+12.4%$48.22MN/A0.0037SGHTSight Sciences1.4824 of 5 stars$3.46-2.3%$3.93+13.7%-33.0%$183M$79.87M-3.53210INGNInogen4.009 of 5 stars$6.60-2.8%$11.00+66.7%-22.7%$182.56M$335.70M-5.741,030PDEXPro-Dex2.111 of 5 stars$51.52-3.7%$56.00+8.7%+138.5%$174.47M$53.84M18.40140News CoverageTLSITriSalus Life Sciences2.053 of 5 stars$4.34-4.6%$10.75+147.7%-32.2%$172.17M$32.14M-3.87106News CoverageUpcoming EarningsPROFProfound Medical1.8255 of 5 stars$5.46-4.2%$11.00+101.5%-41.7%$171.30M$10.68M-4.48150News CoverageELMDElectromed2.5554 of 5 stars$18.82-0.1%$33.50+78.0%+20.8%$157.83M$61.44M25.09160Positive NewsKRMDKORU Medical Systems2.2266 of 5 stars$3.48+2.1%$4.63+32.9%+45.5%$157.34M$33.65M-31.6480News CoverageLNSRLENSAR0.745 of 5 stars$13.10-0.1%$15.00+14.5%+170.9%$154.60M$53.49M-2.70110Positive NewsUpcoming EarningsRCELAvita Medical0.8755 of 5 stars$5.75-0.9%$16.50+187.0%-33.6%$153.32M$64.25M-2.63130LAKELakeland Industries4.6839 of 5 stars$14.45-2.0%$26.00+79.9%-37.0%$140.25M$177.65M-4.802,100Dividend Announcement Related Companies and Tools Related Companies Sight Sciences Alternatives Inogen Alternatives Pro-Dex Alternatives TriSalus Life Sciences Alternatives Profound Medical Alternatives Electromed Alternatives KORU Medical Systems Alternatives LENSAR Alternatives Avita Medical Alternatives Lakeland Industries Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DXR) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DXR Stock Alerts